Status:
COMPLETED
Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation
Lead Sponsor:
Peking University Third Hospital
Conditions:
Adolescent
Adult
Eligibility:
All Genders
18-45 years
Brief Summary
To observe the retinal microvascular alteration during 3 months follow-up after Implantable Collamer Lens (ICL) operation in moderate and high myopia patients using quantitative optical coherence tomo...
Detailed Description
The study object is moderate and high myopia patients, underwent ICL implantation. OCTA was used to image the superficial and deep retinal vascular plexuses before ICL implantation surgery and at 3 mo...
Eligibility Criteria
Inclusion
- 18 to 45 years old;
- Binocular myopia, with a refraction of greater than -3 diopters (D);
- anterior chamber depth (ACD, measured from the endothelium to the crystalline lens) \> 2.8 mm;
- corneal endothelial cell count (cECC) ≥ 2000 cells/mm2;
- stable refraction at least 1 year before surgery;
- unsatisfactory vision with contact lenses or spectacles.
Exclusion
- history of intraocular surgery
- other ocular pathology (uveitis, glaucoma, cataract, keratoconus, severe dry eye, etc.)
- other serious systemic disease (diabetes, uncontrolled hypertension, severe hyperthyroidism, etc.).
Key Trial Info
Start Date :
November 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04443231
Start Date
November 1 2018
End Date
October 1 2019
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191